XML 25 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities        
Net loss [1] $ (16,567) $ (47,954)    
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization [1] 10,090 11,137    
Provision for losses on accounts receivable [1] 2,065 436    
Share-based compensation [1] 3,563 8,682    
Fair value and remeasurement adjustments, non-cash (includes $2,146 and $19,125 from related parties for 2025 and 2024, respectively) [1] 8,405 13,651    
Non-cash interest and other (includes $— and $(3,192) from related parties for 2025 and 2024, respectively) [1] 4,513 (2,661)    
Depreciation of rental merchandise [1] 3,387 4,202    
Net foreign currency (gains) losses [1] (224) 271    
Loss from equity investments [1] 552 4    
Dividends from equity investments [1] 59 37    
Deferred income taxes [1] 8,957 (16,012)    
(Gain) loss on sale or disposal of fixed assets and other [1] (1,350) 111    
Gain on sale and deconsolidation of businesses [1] (80,841) (314)    
Loss on extinguishment of debt [1] 10,427 0    
Gain on senior note exchange [1] (10,532) 0    
Income allocated and fair value adjustment for mandatorily redeemable noncontrolling interests [1] 0 293    
Change in operating assets and liabilities:        
Amounts due to/from clearing brokers [1] 17,818 10,460    
Securities and other investments owned [1] 49,216 192,639    
Securities borrowed [1] 2,127 820,860    
Accounts receivable [1] 3,551 (8,739)    
Prepaid expenses and other assets (includes $2,653 and $(6,267) from related parties for 2025 and 2024, respectively) [1] 5,479 (6,761)    
Accounts payable, accrued expenses and other liabilities [1] (8,961) (21,114)    
Amounts due to/from related parties and partners [1] (1,959) (888)    
Securities sold not yet purchased [1] (3,535) (2,178)    
Deferred revenue [1] (857) (2,668)    
Securities loaned [1] (5,199) (818,137)    
Net cash provided by operating activities [1] 184 135,357    
Cash flows from investing activities        
Purchases of loans receivable (includes $(50,853) and $(12,759) from related parties for 2025 and 2024, respectively) [1] (61,528) (42,903)    
Repayments of loans receivable (includes $32,683 and $20,307 from related parties for 2025 and 2024, respectively) [1] 46,757 39,493    
Sales of loans receivable (includes $6,611 and $— from related parties for 2025 and 2024, respectively) [1] 6,840 22,785    
Proceeds from loan participations sold [1] 3,986 0    
Sale of business, net of cash sold and other [1] 68,901 (184)    
Purchases of property, equipment and intangible assets [1] (6,673) (913)    
Proceeds from sale of property, equipment, intangible assets, and other [1] 7,160 0    
Purchases of equity and other investments [1] (6,621) 0    
Consolidation of VIE [1] 359 0    
Net cash provided by investing activities [1] 59,181 18,278    
Cash flows from financing activities        
Proceeds from revolving line of credit [1] 21,535 17,738    
Repayment of revolving line of credit [1] (24,064) (39,343)    
Proceeds from note payable [1] 850 0    
Repayment of notes payable and other [1] (12,834) (5,361)    
Repayment of term loan [1] (239,274) (30,036)    
Proceeds from term loan [1] 235,550 0    
Redemption of senior notes [1] (145,302) (115,492)    
Payment of debt issuance and offering costs [1] (8,942) (191)    
Payment of contingent consideration [1] (48) (70)    
Payment of employment taxes on vesting of restricted stock [1] 0 (1,170)    
Common dividends paid [1] 0 (16,014)    
Preferred dividends paid [1] 0 (2,015)    
Distribution to noncontrolling interests [1] 0 (1,481)    
Contributions from noncontrolling interests [1] 0 2,502    
Net cash used in financing activities [1] (172,529) (190,933)    
Decrease in cash, cash equivalents and restricted cash [1] (113,164) (37,298)    
Effect of foreign currency on cash, cash equivalents and restricted cash [1] (465) (3,962)    
Net decrease in cash, cash equivalents and restricted cash [1] (113,629) (41,260)    
Cash, cash equivalents and restricted cash from continuing operations, beginning of period 248,651 218,546    
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period 8,025 15,293    
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total 143,047 192,579 $ 256,676 $ 233,839
Cash, cash equivalents and restricted cash from continuing operations, end of period 139,678 181,822    
Cash, cash equivalents and restricted cash from discontinued operations, end of period 3,369 10,757    
Supplemental disclosures:        
Interest paid 28,982 81,737    
Taxes paid $ 932 $ 1,432    
[1] Amounts presented contain results from both continuing and discontinued operations. Refer to Note 3 - Discontinued Operations and Assets Held for Sale for additional information regarding cash flow associated with the results of discontinued operations.